Jafron Biomedical Co.,Ltd. (SHE:300529)
18.58
-0.02 (-0.11%)
Apr 24, 2026, 3:14 PM CST
-15.97% (1Y)
| Market Cap | 14.39B -29.0% |
| Revenue (ttm) | 2.04B -22.6% |
| Net Income | 481.79M -40.1% |
| EPS | 0.63 -37.8% |
| Shares Out | 774.36M |
| PE Ratio | 29.52 |
| Forward PE | 26.26 |
| Dividend | 0.80 (4.30%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 5,399,003 |
| Average Volume | 4,333,212 |
| Open | 17.57 |
| Previous Close | 18.60 |
| Day's Range | 17.57 - 18.71 |
| 52-Week Range | 17.27 - 24.98 |
| Beta | 0.46 |
| RSI | 57.13 |
| Earnings Date | Apr 28, 2026 |